LOW-VOLUME · PSORIASIS
calcipotriene Side Effects
calcipotriene (also sold as Dovonex) is a LOW-VOLUME FAERS extract #420 of 524 by FAERS report count. Still opens on PSORIASIS: PSORIASIS leads at 720 reports (21.5% of the book).
Data updated 2026-05-15
- 3,344
- FAERS reports
Thinner FAERS book - still a temporal association ledger, not proof of cause. Methodology.
Among 3,344 FAERS reports for calcipotriene, PSORIASIS is the most-reported reaction (720). Volume band LOW-VOLUME #420 of 524 by FAERS report count.
Thinner FAERS extract for calcipotriene (Dovonex) (3,344 reports #420 of 524 by FAERS report count). PSORIASIS leads at 720 reports (21.5% of the book). Sparse books still carry named reaction rows when present; not medical advice.
Counts from the openFDA FAERS extract (2004–2025). Stamps SIGNAL · DEATH-MARKED · HOSP-MID · SEX-BALANCED.
PSORIASIS leads 720 of 3,344 reports
Who reports · age peak 45-64 (SEX-BALANCED)
Sex coding · SEX-BALANCED
Age peak 45-64 (800 reports)
FAERS filings rising toward 2025
Reactions in Death Reports
Death appears on 58 reports (1.7% - MARKED). Reactions below co-occur in those rows only.
| Reaction | Reports |
|---|---|
| DEATH | 27 |
| MYOCARDIAL INFARCTION | 7 |
| CARDIAC ARREST | 5 |
| ACUTE KIDNEY INJURY | 4 |
| ASTHENIA | 4 |
| CIRCULATORY COLLAPSE | 4 |
| PALPITATIONS | 4 |
| TACHYARRHYTHMIA | 4 |
| CHRONIC KIDNEY DISEASE | 3 |
| LOSS OF CONSCIOUSNESS | 3 |
| PAIN | 3 |
| ABDOMINAL PAIN | 2 |
| ACINETOBACTER INFECTION | 2 |
| ANAEMIA | 2 |
| ASCITES | 2 |
| BRADYCARDIA | 2 |
| DEHYDRATION | 2 |
| DYSPNOEA | 2 |
Reactions in Hospitalization Reports
Hospitalization mid-share (440, 13.2%). Co-reported reactions:
| Reaction | Reports |
|---|---|
| CONTUSION | 55 |
| PSORIASIS | 54 |
| HYPERTENSION | 52 |
| ABDOMINAL DISCOMFORT | 50 |
| DIABETES MELLITUS INADEQUATE CONTROL | 47 |
| MOBILITY DECREASED | 44 |
| AMNESIA | 42 |
| BLOOD PRESSURE INADEQUATELY CONTROLLED | 42 |
| OEDEMA PERIPHERAL | 42 |
| COGNITIVE DISORDER | 41 |
| DEPRESSED MOOD | 41 |
| EXERCISE TOLERANCE DECREASED | 41 |
| MEDICATION ERROR | 41 |
| TREATMENT NONCOMPLIANCE | 39 |
| PERIPHERAL SWELLING | 38 |
| DYSPNOEA | 35 |
| MULTIPLE DRUG THERAPY | 33 |
How to read calcipotriene FAERS figures (SIGNAL · DEATH-MARKED · HOSP-MID)
FAERS holds 3,344 voluntary reports linked to calcipotriene (Dovonex), 2004-2025. Death is listed on 58 (1.7%). Hospitalization appears on 440 (13.2%). Top co-reported indication: Psoriasis.
Sparse extract - named reactions and SEX-BALANCED skew still differ by drug; not a complete safety profile.
Read with calcipotriene
Peers ranked by ABS(total_reports), then an ABS(death_share) pole; guide hop follows DEATH-MARKED · HOSP-MID stamps.
ABS(total_reports) peer at 3,350 FAERS cases (Δ 6 heavier vs calcipotriene); DEATH-MARKED · HOSP-MID · MALE-LED vs this page's SIGNAL · DEATH-MARKED · HOSP-MID · SEX-BALANCED.
ABS(total_reports) peer at 3,330 FAERS cases (Δ 14 lighter vs calcipotriene); DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED vs this page's SIGNAL · DEATH-MARKED · HOSP-MID · SEX-BALANCED.
ABS(total_reports) peer at 3,393 FAERS cases (Δ 49 heavier vs calcipotriene); DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED vs this page's SIGNAL · DEATH-MARKED · HOSP-MID · SEX-BALANCED.
ABS(total_reports) peer at 3,396 FAERS cases (Δ 52 heavier vs calcipotriene); DEATH-MARKED · HOSP-MID · FEMALE-LED vs this page's SIGNAL · DEATH-MARKED · HOSP-MID · SEX-BALANCED.
ABS(death_share) pole at 62.1% death-mentioned reports (Δ 60.4 pp vs calcipotriene's DEATH-MARKED): CASELOAD · HOSP-MID.
calcipotriene stamps SIGNAL · SEX-BALANCED; class peers and methodology beat restating the same FAERS caveats on every effects URL.